trimetazidine / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   32 Trials   32 Trials   623 News 
44 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
trimetazidine / Generic mfg.
ChiCTR-TRC-13003298: Oral Trimetazidine for Reducing the Symptoms of Acute Mountain Sickness and Improving Exercise Performance

Completed
4
40
 
Oral Trimetazidine 20mg, Tid ;Oral placebo 20mg, Tid
Institute of Cardiovascular Diseases of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing, China; Level of the institution:, Supported by the Special Health Research Project, the Ministry of Health of the People's Republic of China (201002012)
acute mountain sickness
 
 
ChiCTR-OPC-15006839: RCT Study on Trimetazidine Treatment of Liver Failure

Recruiting
4
180
 
Based on the control group treatment programme and treated with full use of Aspartate ornithine, oral with trimetazidine 20mg / piece, 20mg/ times, 3 times / day, three meals a day, for 4 weeks. ;conventional treatment ;Based on the control group treatment, L-ornithine-L-aspartate (LOLA) 10 mg IV daily
The First Affiliated Hospital of Zhengzhou University; The First Affiliated Hospital of Zhengzhou University, National Science technology research program
liver failure
 
 
ChiCTR2400088581: Bioequivalence test of trimetazidine hydrochloride tablets

Completed
4
56
 
After meals: the test formulation was given in the first phase, and reference formulation was given in the second phase; After meals: the reference formulation was given in the first phase, and test formulation was given in the second phase; Fasting: the test formulation was given in the first phase, and reference formulation was given in the second phase; Fasting: the reference formulation was given in the first phase, and test formulation was given in the second phase
Guangzhou Panyu Central Hospital; Guangzhou Panyu Central Hospital, Sponsor's funding
Cardiovascular disease
 
 
ChiCTR1800017008: Effect of trimetazidine on autonomic nervous function in patients undergoing percutaneous coronary intervention

Not yet recruiting
4
400
 
Routine protocol + Trimetazidine ;Routine protocol, include Low-molecular heparin, aspirin, clopidogrel, statin, ACEI or ARB, purge - receptor blockers and nitrates, depends on status of the disease
the Second Hosptial of Hebei Medical University; the Second Hosptial of Hebei Medical University, Self - financing
Coronary Heart Disease
 
 
2020-001617-21: The Effect of Trimetazidine on Cardiac Function in Patients with Cardiac Amyloidosis. Effekten af Trimetazidin på Hjertefunktion ved Patienter med Hjerteamyloidose.

Not yet recruiting
4
36
Europe
Vastarel
Aarhus University Hospital, Department of Cardiology, Aarhus University Hospital
Wild-Type Transthyretin Cardiac Amyloidosis, Cardiac Amyloidosis Hjerteamyloidose, Diseases [C] - Cardiovascular Diseases [C14]
 
 
CADLVH, ChiCTR1800017876: the effect of trimetazidine on myocardial ischemia, remodeling and long-term prognosis in CAD patients with hypertensive hypertrophy after PCI

Recruiting
4
124
 
trimetazidine ;placebo
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University; Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China Cardiovascular Association-Cardiac Rehabilitation and metabolic therapy research fund
coronary artery disease
 
 
HEARTRIP, NCT03809273: Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI

Recruiting
4
668
RoW
Yangxinshi, Trimetazidine, Yangxinshi mimic, Trimetazidine mimic
Shenyang Northern Hospital
Percutaneous Coronary Intervention
12/20
12/20
2021-001564-26: Evaluation of the cardioprotective metabolic effect of trimetazidine in patients with myocardial ischaemia Valutazione dell’effetto metabolico cardioprotettivo della Trimetazidina in pazienti con ischemia miocardica

Not yet recruiting
4
10
Europe
Trimetazidina, [Trimetazidina], Tablet, VASTAREL - 20 MG COMPRESSE RIVESTITE 60 COMPRESSE
FONDAZIONE TOSCANA GABRIELE MONASTERIO, Fondazione Toscana Gabriele Monasterio
Patients with clinical diagnosis of Inducible Myocardial Ischemia (exercise stress test positive for electrocardiographic criteria and /or symptoms) Pazienti con diagnosi clinica di cardiopatia ischemica (test da sforzo positivo per criteri elettrocardiografici e/osintomi), Patients with Inducible Myocardial Ischemia Pazienti con cardiopatia ischemica, Diseases [C] - Cardiovascular Diseases [C14]
 
 
NCT04661709: Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris

Not yet recruiting
4
502
NA
Wen Xin granule, WXG, Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet, Atorvastatin Calcium, Isosorbide Mononitrate Tab 20 MG, Metoprolol Tartrate Tab 25 MG, Aspirin Enteric-coated Tablets, WXG placebo, Trimetazidine Dihydrochloride Tablets, glyceryl trinitrate
Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Special Project of National Traditional Chinese Medicine Clinical Research Base of State Administration of Traditional Chinese Medicine, National Natural Science Foundation of China
Coronary Heart Disease, Unstable Angina, Chinese Herbal Medicine
03/23
06/23
CACTuS - TMZ, NCT05633563: The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis

Completed
4
24
Europe
Trimetazidine, Placebo
Steen Hvitfeldt Poulsen
Transthyretin Amyloid Cardiopathy, Mitochondrial Pathology
06/23
06/23
ChiCTR2300074471: To explore whether trimetazidine can improve cardiac function in adult cyanotic congenital heart disease patients with hypoxia

Not yet recruiting
4
80
 
placebo; Trimetazidine hydrochloride tablets
Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine; Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, National Natural Science Foundation of China (No. : U20A2018)
Cyanotic congenital heart disease
 
 
NCT05540184: Allopurinol and Trimetazidine as a Preventive of Acute Kidney Injury in PCI Patients

Recruiting
4
124
RoW
Trimetazidine 35 mg, Vastarel MR, Allopurinol 300 MG, Zyloric 300mg, Normal saline, 0.9 NS
Beni-Suef University, Cairo University
AKI - Acute Kidney Injury
09/25
09/25
ChiCTR2300074976: A single-arm clinical trial to evaluate the efficacy and safety of Simvastatin, Orlistat, and Trimetazidine in combination with second-line treatment drugs for advanced liver cancer

Recruiting
4
43
 
Patients with advanced liver cancer received Simvastatin 20mg po qn, Orlistat 120mg po tid, Trimetazidine 20mg po tid combined with second-line treatment drugs for advanced liver cancer
Affiliated Hospital of Qingdao University; Affiliated Hospital of Qingdao University, Self-funding for scientific research
Liver cancer
 
 
2007-002893-76: MEtabolic Therapy with Trimetazidine in Acute heart failure: an open pilot randomized trial (The METTA – PRAGUE 10 Trial)

Ongoing
3
100
Europe
Preductal MR, Preductal MR
Charles University in Prague, Third Faculty of Medicine
Acute Heart Failure
 
 
2010-022134-89: Efficacy and safety of trimetazidine in patients with angina having been treated by dilatation of coronary arteries.

 
3
820
Europe, RoW
S06790, S06790, VASTAREL MR 35mg, VASTAREL MR 35mg
I.R.I.S., ADIR
Patients with Angina pectoris having been treated by Percutaneous Coronary Intervention
 
 
NCT06656442: "The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"

Recruiting
3
60
RoW
Trimetazidine, Vastarel Mr, Metacardia Mr
Ain Shams University
Acute Ischemic Stroke
12/25
12/25
NCT04939857: Effect of Trimetazidine on Radiotherapy-induced Heart Damage.

Not yet recruiting
2/3
80
NA
Trimetazidine
Peking University Third Hospital
Cardiotoxicity
07/22
08/22
ACTRN12622000474752p: TIDE (Trimetazidine in bipolar depression): A double-blind, randomised, placebo-controlled trial

Not yet recruiting
2
180
 
Deakin University, Stanley Medical Research Institute
Bipolar depression
 
 
ACTRN12622000474752: TIDE (Trimetazidine in bipolar depression): A double-blind, randomised, placebo-controlled trial

Not yet recruiting
2
260
 
Deakin University, Stanley Medical Research Institute
Bipolar depression
 
 
2016-002270-12: Clinical study to evaluate the preventive effect of trimetazidine on cardiac toxicity from chemotherapy in patients with breast cancer Studio clinico per valutare l'effetto preventivo della trimetazidina sulla tossicit¿ cardiaca da chemioterapia in pazienti con tumore della mammella

Not yet recruiting
2
242
Europe
VASTAREL, Film-coated tablet, VASTAREL - 20 MG COMPRESSE RIVESTITE 60 COMPRESSE
AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, AZIENDA OSPEDALIERO UNIVERSITARIA PISANA
BREAST CANCER CARCINOMA DELLA MAMMELLA, BREAST CANCER TUMORE DELLA MAMMELLA, Diseases [C] - Cancer [C04]
 
 
PREMIER, NCT04760821: Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19

Recruiting
2
80
RoW
Trimetazidine
Ministry of Health, Brazil, InCor Heart Institute
Acute Respiratory Distress Syndrome, Covid19, Myocardial Injury
04/21
04/21
2020-005018-17: Safety and tolerability of Trimetazidine in amyotrophic lateral sclerosis (ALS) Het bestuderen van de veiligheid en verdraagzaamheid van Trimetazidine bij patiënten met amyotrofische laterale sclerose (ALS)

Ongoing
2
36
Europe
Trimetazidine, 201600930, Tablet, Vastarel
The University of Queensland, FightMND
Patients suffering from amyotrophic lateral sclerosis (ALS) Patiënten met de ziekte amyotrofische laterale sclerose (ALS), Patients with ALS, also known as a motor neuron disease (MND) or as Lou Gehrig's Disease Patiënten met ALS, Diseases [C] - Nervous System Diseases [C10]
 
 
2018-002170-52: TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction Trimetazidine voor diastolisch hartfalen

Not yet recruiting
2
25
Europe
Vastarel, Film-coated tablet, Vastarel
VU University Medical Center (VUmc), Amsterdam Cardiovascular Sciences, VUmc/Department of Cardiology
Heart failure with preserved ejection fraction (HFpEF), Diastolic heart failure Diastolisch hartfalen, Diseases [C] - Cardiovascular Diseases [C14]
 
 
MetFlex, NCT04788745: Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)

Completed
2
21
Europe, RoW
Trimetazidine Dihydrochloride
The University of Queensland, FightMND, UMC Utrecht, King's College London, Julius Clinical
Amyotrophic Lateral Sclerosis, Motor Neuron Disease
05/23
05/23
NCT05556005: Efficacy of Trimetazidine in Diabetic Patients

Recruiting
2
60
RoW
Trimetazidine Dihydrochloride, Vasteral mr, Placebo
Ain Shams University
Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies
09/23
09/23
MAFLD, NCT06140953: Benefits of Trimetazidine in Pateints

Recruiting
2
60
RoW
conventional treatment, conventional treatment ( anti diabetic drugs and antihyperlipidimic drugs ), Furosemide or other alternatives , Niaspan or other alternatives, conventional therapy, Trimetazidine, furosemide or other alternative , niaspan or other alternative
October 6 University
Non-Alcoholic Fatty Liver Disease
06/24
09/25
NCT05147194: The Effects of TMZ on Diabetic Nephropathy

Not yet recruiting
2
150
NA
Trimetazidine
Tongji Hospital
Diabetic Nephropathies
12/23
12/23
ACTRN12620000945921: Safety and tolerability of Trimetazidine in amyotrophic lateral sclerosis (ALS)

Not yet recruiting
1/2
36
 
The University of Queensland, FightMND
Amyotrophic Lateral Sclerosis
 
 
ACTRN12620000945921p: Safety and tolerability of Trimetazidine in amyotrophic lateral sclerosis (ALS)

Not yet recruiting
1/2
36
 
The University of Queensland, FightMND
Amyotrophic Lateral Sclerosis
 
 
NCT06459193: Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

Recruiting
1/2
60
RoW
Trimetazidine, Placebo
Minia University
Peripheral Neuropathy Due to Chemotherapy
11/24
11/24
ChiCTR-IIR-17012737: Bioequivalence study of trimetazidine hydrochloride sustained release tablets

Not yet recruiting
1
52
 
investigational product
Xiyuan Hospital, CACMS; Baimeite Biopharmaceutical Co Ltd, sponsor's funding
Not Applicable
 
 
ChiCTR1800016293: Shenmai injection and the main components of ginseng total saponinsThe mechanism of influence on metabolic group of heart failure

Recruiting
1
100
 
blank ;Use of Shenmai vein ;Oral use of Trimetazidine ;Levocarnitine intravenous use
Zhejiang Province People's Hospital; Zhejiang Province People's Hospital, self
Heart failure
 
 
ChiCTR2000035293: Bioequivalence of Trimetazidine Dihydrochloride Modified Release Tablets (Fasting /Feeding) in the Healthy Human Body: a Randomized Cross-Over Controlled Trial

Recruiting
1
48
 
phase I: T; phase II: R ;phase I: R; phase II: T ;phase I: T; phase II: R ;phase I: R; phase II: T
Xiangya Boai Rehabilitation Hospital; Synco (K.K.) Limited, Synco (K.K.) Limited
Pharmacokinetics and Bioequivalence Study in human
 
 
ChiCTR2300077163: A multicenter randomized controlled study of the effects of wide-chest aerosol on anxiety and depression in patients with coronary heart disease after PCI

Not yet recruiting
1
330
 
All patients received routine treatment from the hospital's medical staff. These include predictive drugs (aspirin, beta-blockers, statins, ACEI), symptom-improving drugs (nitrates, calcium antagonists), and other metabolic drugs (trimetazidine). Try to keep the type and dosage of medication the same. In this group, on top of the basic treatment, the use of broad chest aerosol was increased, and the broad chest aerosol was sprayed sublingual, 3 sprays/time, 3 times/day, for 48 weeks.; All patients received routine treatment from the hospital's medical staff. These include predictive drugs (aspirin, beta-blockers, statins, ACEI), symptom-improving drugs (nitrates, calcium antagonists), and other metabolic drugs (trimetazidine). Try to keep the type and dosage of medication the same. In this group, on top of the basic treatment, the use of a placebo was increased, and the use method, dosage, and duration of the placebo were the same as that of wide-chest aerosol.
Affiliated Hospital of Hangzhou Normal University; Affiliated Hospital of Hangzhou Normal University, Hangzhou Municipal Health Commission -- Hangzhou Bio-medicine and health Industry development support science and technology project
Anxiety and depression after PCI of coronary heart disease
 
 
ChiCTR1900025018: A Randomized, Double-Blind, Placebo-Controlled Trial for the Myocardial Protection of Trimetazidine in Elderly Coronary Artery Disease Patients Undergoing Non-cardiac Surgery

Completed
N/A
60
 
trimetazidine ;Nil
Shenzhen People's Hospital; None, Shenzhen Science and Technology Research Fund
coronary artery patients
 
 
ChiCTR-INR-17010449: Preventive effect of coenzyme Q10 and trimetazidine on contrast-induced nephropathy in patients with renal insufficiency undergoing percutaneous coronary intervention

Recruiting
N/A
146
 
coenzyme Q10 and trimetazidine ;placebo
The second Hospital of Hebei Medical University; he second Hospital of Hebei Medical University No, Project of science and Technology Department of Hebei Province
contrast-induced nephropathy
 
 
ChiCTR1800015000: Trimetazidine modified release tablets in Angina and Poor muscle function (TAP): a randomized controlled study

Recruiting
N/A
60
 
A dose of 35mg oral TMZ is administered during 2 times of meal a day besides conventional treatments in TMZ group for 3 months. ;Routine treatment
Chinese PLA General Hospital; Chinese PLA General Hospital, China Foundation for the Promotion of Health
stable angina
 
 
ChiCTR1900021275: Protective effect of trimetazidine and nicorandil on renal function in patients undergoing elective percutaneous coronary intervention

Not yet recruiting
N/A
400
 
standardized hydration treatment ;Trimetazidine+standardized hydration treatment ;Nicorandil+standardized hydration treatment ;Trimetazidine+nicorandil+standardized hydration treatment
Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, the National Natural Science Foundation of China
Contrast-induced nephropathy
 
 
NCT04702906: Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity

Not yet recruiting
N/A
40
NA
standard treatment, trimetazidine hydrochloride "metacardia" ® 20 mg tablet
Tanta University
Aluminum Phosphide Poisoning
06/21
07/21
ChiCTR1900021608: A Randomized Controlled Trial for the Effect of Yiqi Huoxue Decoction on Exercise Tolerance in Patients with Chronic Stable Coronary Heart Disease

Not yet recruiting
N/A
108
 
Yiqi Huoxue decoction; ;Trimetazidine
Dongfang Hospital; Dongfang Hospital Affiliated to Beijing University of Chinese Medicine, Municipal Finance for Science and Technology; Hospital Self-financing
Chronic Stable Coronary Disease
 
 
ChiCTR2000038559: Feasibility and application of trimetazidine in 18F-FDG PET myocardial metabolic imaging of diabetic mellitus patients

Completed
N/A
 
The Third Affiliated Hospital of Suzhou University / Changzhou First People's Hospital; The Third Affiliated Hospital of Suzhou University / Changzhou First People's Hospital, Science and Technology Plan of Jiangsu Province-Standardization of Diagnosis and Treatment of Key Diseases Project
diabetic mellitus, coronary artery disease
 
 
V-GOOD, NCT06464276: Effectiveness and Tolerability of Trimetazidine 80mg Once Daily in Patients With Chronic Coronary Syndrome: The Study

Completed
N/A
800
RoW
No intervention
Ministry of Health, Brazil, Servier
Chronic Coronary Syndrome, Stable Angina
06/22
09/22
NCT06298045: Effectiveness of a Combination of Trimetazidine With One Hemodynamic Agent in Patients Recently Diagnosed With Stable Angina and Still Symptomatic Despite First Line Hemodynamic Therapy

Recruiting
N/A
600
Europe
Servier Affaires Médicales
Stable Angina
03/25
03/25
METHOD, NCT05210465: Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction

Completed
N/A
36
RoW
speckle tracking mode of the stress ECHO test with dobutamine
Servier Russia
Coronary Artery Disease
11/23
04/24

Download Options